Cargando…

Editorial: Refractory Pituitary Adenoma—Current Challenges and Emerging Treatments

Detalles Bibliográficos
Autores principales: Wang, Renzhi, Zhou, Cuiqi, McCormack, Ann I., Mamelak, Adam N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959341/
https://www.ncbi.nlm.nih.gov/pubmed/35355554
http://dx.doi.org/10.3389/fendo.2022.868174
_version_ 1784677132166758400
author Wang, Renzhi
Zhou, Cuiqi
McCormack, Ann I.
Mamelak, Adam N.
author_facet Wang, Renzhi
Zhou, Cuiqi
McCormack, Ann I.
Mamelak, Adam N.
author_sort Wang, Renzhi
collection PubMed
description
format Online
Article
Text
id pubmed-8959341
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89593412022-03-29 Editorial: Refractory Pituitary Adenoma—Current Challenges and Emerging Treatments Wang, Renzhi Zhou, Cuiqi McCormack, Ann I. Mamelak, Adam N. Front Endocrinol (Lausanne) Endocrinology Frontiers Media S.A. 2022-03-09 /pmc/articles/PMC8959341/ /pubmed/35355554 http://dx.doi.org/10.3389/fendo.2022.868174 Text en Copyright © 2022 Wang, Zhou, McCormack and Mamelak https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Wang, Renzhi
Zhou, Cuiqi
McCormack, Ann I.
Mamelak, Adam N.
Editorial: Refractory Pituitary Adenoma—Current Challenges and Emerging Treatments
title Editorial: Refractory Pituitary Adenoma—Current Challenges and Emerging Treatments
title_full Editorial: Refractory Pituitary Adenoma—Current Challenges and Emerging Treatments
title_fullStr Editorial: Refractory Pituitary Adenoma—Current Challenges and Emerging Treatments
title_full_unstemmed Editorial: Refractory Pituitary Adenoma—Current Challenges and Emerging Treatments
title_short Editorial: Refractory Pituitary Adenoma—Current Challenges and Emerging Treatments
title_sort editorial: refractory pituitary adenoma—current challenges and emerging treatments
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959341/
https://www.ncbi.nlm.nih.gov/pubmed/35355554
http://dx.doi.org/10.3389/fendo.2022.868174
work_keys_str_mv AT wangrenzhi editorialrefractorypituitaryadenomacurrentchallengesandemergingtreatments
AT zhoucuiqi editorialrefractorypituitaryadenomacurrentchallengesandemergingtreatments
AT mccormackanni editorialrefractorypituitaryadenomacurrentchallengesandemergingtreatments
AT mamelakadamn editorialrefractorypituitaryadenomacurrentchallengesandemergingtreatments